Literature DB >> 8228630

Effect of phospholipids and bile acids on cholesterol nucleation time and vesicular/micellar cholesterol in gallbladder bile of patients with cholesterol stones.

D Jüngst1, T Lang, P Huber, V Lange, G Paumgartner.   

Abstract

Supersaturation and rapid nucleation of cholesterol in bile are of key importance in the pathogenesis of cholesterol gallstones. While the effects of bile acids and phospholipids on cholesterol saturation of bile have been extensively studied, their influence on the cholesterol nucleation time has not been compared. We, therefore, investigated whether increases of bile acid or phospholipid concentrations in bile by in vitro supplementation affect the cholesterol nucleation time. Bile samples were obtained at surgery from patients with cholesterol gallstones. Prior to the nucleation assay the bile samples were divided into 0.5-ml aliquots and supplemented with 1.25, 2.5, 5.0, and 10.0 mumol/ml of different phosphatidylcholines (PC-dimyristoyl, PC-dipalmitoyl, PC-distearoyl, and extracted biliary PCs) or with 5.0, 10.0, and 20.0 mumol/ml of bile acids (glycine or taurine conjugates of cholic acid, deoxycholic acid, or chenodeoxycholic acid). The increase of phosphatidylcholine or bile acid concentration decreased the mean cholesterol saturation index to a similar extent (PC: 0.1-0.3; BA: 0.1-0.2). Supplementations of bile with increasing amounts of synthetic or biliary PCs caused a marked prolongation of the nucleation time in bile from 1.5 +/- 0.2 up to > or = 21 days or 2.5 +/- 0.7 up to > or = 21 days. Concurrently, biliary cholesterol was shifted from vesicles to mixed micelles and the cholesterol/phospholipid ratio of the remaining vesicles was progressively lowered. In contrast, the addition of bile acids to gallbladder bile did not affect the cholesterol nucleation time (2.2 +/- 0.3 days), the percentage of vesicular cholesterol, or the cholesterol/phospholipid ratio of vesicles and micelles.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228630

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  18 in total

1.  Gallbladder dysfunction enhances physical density but not biochemical metastability of biliary vesicles.

Authors:  Y Sunami; S Tazuma; G Kajiyama
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

2.  Self-assembly of helical ribbons.

Authors:  Y V Zastavker; N Asherie; A Lomakin; J Pande; J M Donovan; J M Schnur; G B Benedek
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.

Authors:  Annika Gauss; Robert Ehehalt; Wolf-Dieter Lehmann; Gerhard Erben; Karl-Heinz Weiss; Yvonne Schaefer; Petra Kloeters-Plachky; Adolf Stiehl; Wolfgang Stremmel; Peter Sauer; Daniel Nils Gotthardt
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

4.  Composition of gallbladder bile in healthy individuals and patients with gallstone disease from north and South India.

Authors:  V Jayanthi; S Sarika; Joy Varghese; V Vaithiswaran; Malay Sharma; Mettu Srinivas Reddy; Vijaya Srinivasan; G M M Reddy; Mohamed Rela; S Kalkura
Journal:  Indian J Gastroenterol       Date:  2016-09-16

5.  The effects of dietary phospholipids enriched with phosphatidylethanolamine on bile and red cell membrane lipids in humans.

Authors:  R Pakula; F M Konikoff; M Rubin; Y Ringel; Y Peled; A Tietz; T Gilat
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 6.  Cholesterol crystallisation in bile.

Authors:  P Portincasa; K J van Erpecum; G P Vanberge-Henegouwen
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

7.  Less hydrophobic phosphatidylcholine species simplify biliary vesicle morphology, but induce bile metastability with a broad spectrum of crystal forms.

Authors:  Minoru Sakomoto; Susumu Tazuma; Kazuaki Chayama
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

8.  Quantitative assessment of comparative potencies of cholesterol-crystal-promoting factors: relation to mechanistic characterization.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

9.  Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.

Authors:  I Jane Cox; Amar Sharif; Jeremy F L Cobbold; Howard C Thomas; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 10.  Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes.

Authors:  Jill L Sherriff; Therese A O'Sullivan; Catherine Properzi; Josephine-Lee Oddo; Leon A Adams
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.